Insiders · Profile

Hawryluk P. Kent

President & CEO at MBX Biosciences · Director at MetaVia. Filing since 10 Aug 2016. CIK 0001673991

Company
Date
Role
Action
Shares
Amount
Of holding
6 May 2026
President & CEO
Sold at will
607
$17.93K
0.1%
13 Mar 2026
President & CEO
Bought
18,500
$525.66K
4.0%
20 Oct 2025
President & CEO
Bought
20,000
$272.79K
4.5%
4 Feb 2025
President & CEO
Bought
50,000
$534.50K
12.6%
10 Mar 2017
Director
Bought
25,000
$236.75K
43.9%
10 Aug 2016
Director
Bought
25,000
$250.00K
78.4%
6 decisions on file.